announcing conference call with Steve Jobs.
compname says expects fiscal 2021 results to be positive.
sees q3 earnings per share $1.45 to $1:51.
q3 revenue rose 5 percent to $839.9 million.
compname says revises fy guidance and revises q1 adjusted results.
compname reports q1 results for fiscal year 2020; announces first quarter 2021 guidance; restructure its financial outlook.
compname reports third quarter 2021 results and announces share repurchase program of up to $1 billion.
q1 revenue rose 4 percent to $38.2 billion.
q3 earnings per share $1.05 excluding items.
releases q3 results; also had less of a revenue tailwind.
qtrly average quarterly revenue increased 6% versus a year ago.
q1 sales rose 1 percent to $1.1 billion.
qtrly pharmaceutical distribution segment down compared to q4 of 2020 as we begin to anniversary 2 strategic long-term contract renewals.
compname says q1 revenue rose approximately 14 percent to $2.1 billion.
continues to focus on cost structures; its business will retain a full-time workforce and continues to expand its operating base.
q2 adjusted operating income $486 million.
